The Head of Quality China, LPB has overall responsibility over the Quality functions of the site, leading the Quality Assurance & Quality Control departments. The role is a member of the Site Leadership Team and reports solid line into the Head of Quality Operations, Clinical Development & Manufacturing, and dotted line into the General Manager China, LPB.   In the start-up phase of the project, the role plays a critical part in establishing the Quality functions, the validation of the site and its preparedness for cGMP clinical to commercial production.  The role ensures establishment of procedures, policies and practices in full compliance and consistency with Lonza’s global quality standards. Upon completion of the project phase, the role will assumes accountability of Quality (QA & QC).

龍沙（中國(guó)）投資有限公司成立于2003年9月，是瑞士龍沙集團(tuán)全資在廣州設(shè)立的投資性公司。公司旨在于醫(yī)藥、化工及生命科學(xué)領(lǐng)域進(jìn)行投資和再投資，同時(shí)提供以下服務(wù)：

-協(xié)助或代理龍沙所投資企業(yè)的貨物及設(shè)備采購(gòu)業(yè)務(wù)，并在國(guó)內(nèi)外市場(chǎng)銷售他們的產(chǎn)品；

-為龍沙所投資企業(yè)提供售后服務(wù)、技術(shù)支持及人力資源服務(wù)；

-為投資者提供咨詢服務(wù)并為龍沙的關(guān)聯(lián)公司提供市場(chǎng)信息、投資政策等咨詢服務(wù)。